Carina Häbel
Viðskiptavinur Zinzino
Velkomin/n! Ég hef haft frábæra reynslu af vörunum mínum og ég held að þú munir elska þær líka. Láttu mig vita hvað þér finnst!
Investor relations
Financial calendar
Zinzino Interim report Q3 2024
Zinzino Delårsrapport Q3 2024
Zinzino Bokslutskommuniké 2024
Zinzino Year-End Report 2024
Annualreport 2024
Årsredovisning 2024
Financial reports
Press releases
ZINZINO AB (PUBL): Zinzino announces Canary Islands as next step in its global expansion
miðvikudagur, 13. nóvember 2024 15:00
OpnaZINZINO AB (PUBL): Share subscription due to directed set-off issues
fimmtudagur, 19. september 2024 15:30
OpnaZINZINO AB (PUBL.): ZINZINO ACQUIRES 49% OF CYPRIOT OLIVE OIL PRODUCER CLEANTHI ALPHA-OLENIC LTD
fimmtudagur, 27. júní 2024 11:00
OpnaZINZINO AB (PUBL): LETTER OF INTENT TO ACQUIRE ZURVITA INCREASES DISTRIBUTION POWER IN NORTH AMERICA
mánudagur, 17. júní 2024 11:00
OpnaZINZINO AB (PUBL): Zinzino announces Serbia as next step in its global expansion
þriðjudagur, 11. júní 2024 15:30
OpnaZINZINO AB (PUBL): Zinzino now seeks acquisitions in the US and Asia to increase distribution power
föstudagur, 7. júní 2024 12:00
OpnaZINZINO AB (PUBL): Zinzino acquires assets in Xelliss – strategic reinforcement in southern Europe and in the microalgae spirulina
sunnudagur, 12. maí 2024 13:00
OpnaZINZINO AB (PUBL): NOTICE OF ANNUAL GENERAL MEETING IN ZINZINO AB ON MAY 27, 2024
föstudagur, 26. apríl 2024 08:00
OpnaZINZINO AB (PUBL): Zinzino and ACN, enter a strategic partnership in Europe, and in connection with it Zinzino carries out a directed new issue of B shares for SEK 10.4 million.
mánudagur, 29. janúar 2024 10:00
OpnaZINZINO AB (PUBL): Zinzino changes Certified Adviser to Carnegie Investment Bank AB (publ)
fimmtudagur, 30. nóvember 2023 09:00
OpnaZINZINO AB (PUBL): Zinzino announces Mexico as next step in its global expansion
föstudagur, 22. september 2023 08:00
OpnaZINZINO AB (PUBL): Announcement from the annual general meeting
miðvikudagur, 31. maí 2023 16:20
OpnaZINZINO AB (PUBL.): NOTICE TO THE ANNUAL MEETING OF ZINZINO AB ON MAY 31, 2023
þriðjudagur, 2. maí 2023 08:00
OpnaZinzino AB (publ.) cancels warrants that have not been exercised
þriðjudagur, 2. maí 2023 08:00
OpnaZINZINO AB (PUBL): Zinzino launches Turkey as a next market on their road towards global expansion
þriðjudagur, 7. mars 2023 14:30
OpnaGrowing interest in personal health and customized supplements can be a great investment case
mánudagur, 28. nóvember 2022 14:30
OpnaZINZINO AB (PUBL): Share subscription due to directed offset issue
miðvikudagur, 26. október 2022 16:30
OpnaZINZINO AB (PUBL): Announcement from the Annual General Meeting
þriðjudagur, 31. maí 2022 18:00
OpnaNotice of Annual General Meeting of Zinzino AB on May 31, 2022
föstudagur, 29. apríl 2022 12:00
OpnaZinzino announces the launch of Singapore as next step in their global expansion
fimmtudagur, 7. apríl 2022 11:30
OpnaZINZINO AB (PUBL): Zinzino acquires brand portfolio with Swiss skincare and supplements
miðvikudagur, 6. apríl 2022 09:30
OpnaZINZINO AB (PUBL): MEMBERS OF THE NOMINATION COMMITTEE FOR ZINZINO AB'S ANNUAL GENERAL MEETING IN 2022
fimmtudagur, 18. nóvember 2021 14:00
OpnaZINZINO AB (PUBL): Zinzino announces the launch of South Africa as next step in their global expansion
þriðjudagur, 9. nóvember 2021 11:30
OpnaZINZINO AB (PUBL): Zinzino announces launch of Taiwan as next step in the global expansion
fimmtudagur, 9. september 2021 13:00
OpnaZINZINO AB (PUBL): Zinzino announces the launch of Malaysia as next step in their global expansion
fimmtudagur, 3. júní 2021 11:00
OpnaZINZINO AB (PUBL): A new signature BalanceOil from the pioneers of test-based nutrition
fimmtudagur, 15. apríl 2021 15:00
OpnaZINZINO AB (PUBL): Zinzino announces the launch of India as next step in their global expansion strategy
þriðjudagur, 6. apríl 2021 14:00
OpnaZINZINO AB (PUBL): Further expansions of the Zinzino global web shop
þriðjudagur, 15. desember 2020 16:15
OpnaZINZINO AB (PUBL): ZINZINO MOVES TO THE PREMIER SEGMENT OF FIRST NORTH GROWTH MARKET
miðvikudagur, 16. september 2020 10:00
OpnaZINZINO AB (PUBL): PRELIMINARY SALES REPORT SECOND QUARTER 2020
föstudagur, 28. ágúst 2020 08:00
OpnaZINZINO AB (PUBL): ONE-TIME EFFECT DUE TO CHANGED ACCOUNTING FOR DISTRIBUTOR REMUNERATION IMPROVES Q1 2020 WITH SEK 22.2 MILLION BEFORE TAX
þriðjudagur, 5. maí 2020 12:00
OpnaZINZINO AB (PUBL): PRELIMINARY SALES REPORT NOVEMBER 2019
miðvikudagur, 11. desember 2019 10:30
OpnaZINZINO AB (PUBL): Zinzino and Life Leadership collaborate to provide test-based nutrition to expanding markets
föstudagur, 25. október 2019 16:40
OpnaZinzino AB (PUBL): Interim Report for the third Quarter 2018
fimmtudagur, 15. nóvember 2018 08:00
OpnaZINZINO AB (PUBL): THE BOARD DECIDES TO ISSUE 200 000 STOCK OPTIONS
mánudagur, 15. október 2018 15:00
OpnaZINZINO AB (PUBL): PRELIMINARY SALES REPORT THIRD QUARTER 2018
fimmtudagur, 11. október 2018 13:00
OpnaZINZINO AB (PUBL): PRELIMINARY SALES REPORT SECOND QUARTER 2018
fimmtudagur, 5. júlí 2018 13:00
OpnaZINZINO AB (PUBL.) APPOINTED “GROWTH COMPANY OF THE YEAR 2017” BY DIRECT SELLING SWEDEN
föstudagur, 1. júní 2018 11:00
OpnaZINZINO AB (PUBL): Q1; CONTINUED SOUND GROWTH AND STRONG PROFITABILITY IMPROVEMENT, EBITDA RISING BY 45%
þriðjudagur, 15. maí 2018 08:00
OpnaZINZINO AB (PUBL): PRELIMINARY SALES REPORT FIRST QUARTER 2018
þriðjudagur, 10. apríl 2018 13:00
OpnaZINZINO LAUNCHES NEW PRODUCT: ENERGY BAR - DELICIOUS AND HEALTHY!
mánudagur, 12. mars 2018 17:00
OpnaZINZINO AB (PUBL): STRONG GROWTH AND PROPOSAL FOR GREATLY INCREASED DIVIDENDS
miðvikudagur, 28. febrúar 2018 08:00
OpnaZINZINO AB (PUBL): PRELIMINARY SALES REPORT FOR Q4 AND 2017 WITH PROPOSAL TO INCREASE DIVIDEND
föstudagur, 19. janúar 2018 18:00
OpnaInterim report, July – September 2017: IMPROVED GROSS MARGINS AND STRONG GROWTH IN THE DOMESTIC MARKET.
mánudagur, 13. nóvember 2017 08:30
OpnaZinzino launches groundbreaking product: BalanceOil Vegan for the heart and brain
föstudagur, 20. október 2017 13:00
OpnaZINZINO AB (PUBL): CORRECTION: PRELIMINARY SALES REPORT THIRD QUARTER 2017
þriðjudagur, 10. október 2017 17:00
OpnaZINZINO AB (PUBL): PRELIMINARY SALES REPORT THIRD QUARTER 2017
mánudagur, 9. október 2017 11:00
OpnaInterim Report, Zinzino, April – June 2017: Very strong growth of 28% and full-scale launch of a new digital platform
fimmtudagur, 31. ágúst 2017 09:00
OpnaZINZINO AB (PUBL): PRELIMINARY SALES REPORT SECOND QUARTER 2017
þriðjudagur, 4. júlí 2017 12:00
OpnaZINZINO LAUNCHES VIVA, A NEW DIETARY SUPPLEMENT PROMOTING BETTER SLEEP, REDUCING STRESS AND INCREASING WELL-BEING
föstudagur, 30. júní 2017 15:00
OpnaZinzino AB (publ.) appointed “Growth Company of the Year 2016” in direct sales
föstudagur, 2. júní 2017 16:00
OpnaZinzino begins selling in Switzerland ”Rich in capital and an important market”
þriðjudagur, 16. maí 2017 16:00
OpnaInterim Report, January – March 2017: Zinzino continues to deliver strong growth and is well prepared for increased profitability
miðvikudagur, 10. maí 2017 09:00
OpnaZinzino taking the Omega-6/Omega-3 concept to new heights with water-miscible AquaX oil
fimmtudagur, 7. júlí 2016 16:24
OpnaZinzino expands sales to all EU countries “We see a huge potential”
þriðjudagur, 5. júlí 2016 11:10
OpnaYear-End Report 1st January - 31st December 2015, Zinzino AB (publ)
mánudagur, 29. febrúar 2016 11:53
OpnaSweden's Zinzino is improving its foothold in Europe – with the establishment of operations in Germany
mánudagur, 22. febrúar 2016 08:00
OpnaZinzino launches Zinzino LeanShake – a nutritious meal replacement for weight control
föstudagur, 11. desember 2015 11:58
OpnaInterim Report July 1 - September 30, 2015 Zinzino AB (publ)
mánudagur, 23. nóvember 2015 15:28
OpnaSwedish Zinzino continues to grow internationally with its establishment in Canada
fimmtudagur, 17. september 2015 09:28
OpnaZinzino AB (publ) acquires further 13.8 per cent of Faun Pharma AS – safeguarding continued research and expanded product range
föstudagur, 6. mars 2015 10:29
OpnaFinancial Statements 1 January - 31 December 2014, Zinzino AB (publ)
föstudagur, 27. febrúar 2015 14:39
OpnaThe stock
Sustainability Report
Read more about our sustainability approach, targets and 2023 performance.
Greta Billing
shares@zinzino.com
+46 73 627 17 54
Fredrik Nielsen
shares@zinzino.com
+46 (0)707 900 174
Certified Adviser
All companies whose shares are to be traded on the Nasdaq First North Premier Growth Market have a certified adviser who guides and supports the company through the listing process. Subsequently, the adviser monitors that the company complies with First North's regulations for providing information to the market and investors. Carnegie Investment Bank AB (publ) is the Certified Adviser for Zinzino AB.
Certified Adviser:
The Company’s Certified Adviser is Carnegie Investment Bank AB (publ)
Phone: +46 (0)73 856 42 65
E-mail: certifiedadviser@carnegie.se
Why invest in Zinzino
A clear global strategy with a growth-driven, future-proof business model
Zinzino is one of Europe’s fastest-growing direct sales companies with an aggressive global expansion strategy. The Scandinavian-based health tech company is currently operating in Europe, North America, Asia, Australia, India and Africa. The overall company strategy and business model is to achieve profitable growth in new as well as existing markets. The massive growth momentum of the past decade is expected to stay constant thanks to the stability and structure of the business model in combination with top-of-the-line digital market tools as well as continuous company acquisitions.
Help improve the health of the world
Our product concept is to give health back to the world. Our goal is to get the best out of people with enthusiasm, encouragement and a great deal of energy. We are the most customer-focused direct sales company in the world. Our most important product concept, Balance, is showing continued good growth and we currently have over 500,000 test results based on blood tests in our database. We are the company that has done the most fatty acid analyses in the world.
Product development at the leading edge
Through efficient product development in-house, the company has developed a number of new products in health in which it owns its own important intellectual property rights. The newly developed products are manufactured in our own efficient production facility which means that we have 100% quality control. Zinzino’s strategy in the coming years includes continued product development at the leading edge.
Strong market position and distribution
Zinzino has strong sales organisations in its principal markets with good relationships with its customer base. The broad product portfolio attracts new customer groups and thereby generates growth. Through an updated IT platform and logistics system, Zinzino is well equipped for the expected sales growth in the coming years.
Attractive cash flow enables increased stock dividends and gives a good direct return
Zinzino’s business has a very strong cash-generating capability. Effective management of working capital combined with investments that quickly generate revenue and marginal improvements generate a strong cash flow. Thus, dividends can be distributed in accordance with the target of at least 50 per cent of the free cash flow.
Deila þessari síðu
Eða afrita hlekk